← Eichor
Study identifier: NCT05080634 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Analysis of Prevalence and Risk Factors Associated With Gastroesophageal Reflux Disease and Esophagitis After Peroral Endoscopic Myotomy

Condition: Achalasia · GERD  ·  Sponsor: Maria Sklodowska-Curie National Research Institute of Oncology

PhaseN/A
Planned participants100
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Achalasia is an uncommon disorder that results from the degeneration of ganglion cells of the myenteric plexus in the lower esophageal wall. Peroral endoscopic myotomy (POEM) is a minimally invasive procedure capable of overcoming limitations of achalasia treatments. This study aimed to: 1) identify the prevalence of reflux esophagitis and asymptomatic GERD in patients who underwent POEM, and 2) evaluate patient and intraprocedural variables associated with post-POEM GERD.

This description comes directly from the study's public registry record.

Talk to the study team

Anna Chaber-Ciopińska, PhD  ·  (+48) 225463044  ·  annachaber@op.pl

Aleksandra Budnicka-Borkowicz, MD  ·  (+48) 791000890  ·  aleksandra.budnicka-borkowicz@coi.pl

Always discuss trial participation with your own doctor first.

Locations (1)

Maria Sklodowska-Curie Institute - Oncology CenterWarsaw, PolandRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05080634